Biotech

All Articles

Gene publisher Volume laying off 131 employees

.Merely days after genetics publisher Tome Biosciences declared concealed working cuts, a clearer pi...

Repare lays off 25% of team as biotech standstills preclinical R&ampD

.Repare Therapeutics is laying off a fourth of its own labor force as the oncology biotech scales ba...

J &amp J declare FDA permission of $6.5 B autoimmune medicine

.Johnson &amp Johnson has actually gotten yet another step towards realizing a profit on its $6.5 bi...

Gain's stage 1 gain paves technique to prove Parkinson's medicine's worth

.Increase Therapies has actually prepared its sights on verifying the efficiency of its own Parkinso...

Actinogen documents brand-new phase 2 information to save clinical depression medicine

.Actinogen Medical's hopes-- as well as stock price-- have rebounded slightly coming from earlier th...

Pfizer and also Crown jewel incorporate Ratio to multibillion-dollar equation

.Flagship Pioneering and also Pfizer have incorporated Quotient into their 10-program relationship, ...

Bayer pens $547M deal to push perimeters of noncoding RNA

.Bayer executives were actually eager to stress and anxiety to Tough this summer months that the Ger...

UK introduces strategies to release 18 new medical trial centers

.In the middle of a yearslong medical trial decrease in the U.K., a new public-private alliance has ...

UPDATE: Genentech telegrams 93 discharges in The golden state after sharing programs to shutter cancer immunology analysis unit

.Complying with the statement of a sizable cutback shot in April as well as a primary rebuilding pro...

Neurocrine's KarXT rival hits in stage 2-- but simply at low dosage

.Neurocrine Biosciences has obtained its hoped-for account in a period 2 mental illness test, delive...